UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabolic syndrome: a clinical and molecular perspective

Annual review of medicine, 2005-01, Vol.56 (1), p.45-62

2005

Volltextzugriff (PDF)

A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus

Cardiovascular diabetology, 2017-09, Vol.16 (1), p.112-12, Article 112

2017

Volltextzugriff (PDF)

Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease

The American heart journal, 2013-12, Vol.166 (6), p.983-989.e7

2013

Volltextzugriff (PDF)

Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial

American journal of kidney diseases, 2013-04, Vol.61 (4), p.579-587

2013

Volltextzugriff (PDF)

Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies

Diabetes therapy, 2013-06, Vol.4 (1), p.119-145

2013

Volltextzugriff (PDF)

Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis

Cardiovascular diabetology, 2013-01, Vol.12 (1), p.3-3

2013

Volltextzugriff (PDF)

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

BMC endocrine disorders, 2010-04, Vol.10 (1), p.7-7, Article 7

2010

Volltextzugriff (PDF)

Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo

Journal of the American Academy of Dermatology, 2012-09, Vol.67 (3), p.379-386

2012

Volltextzugriff (PDF)

A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin

BMC endocrine disorders, 2017-11, Vol.17 (1), p.70-9, Article 70

2017

Volltextzugriff (PDF)

Randomized clinical trial of the safety and efficacy of sitagliptin and metformin co‐administered to Chinese patients with type 2 diabetes mellitus

Journal of diabetes investigation, 2016-09, Vol.7 (5), p.727-736

2016

Volltextzugriff (PDF)

Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis

BMC endocrine disorders, 2008-10, Vol.8 (1), p.14-14, Article 14

2008

Volltextzugriff (PDF)

Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes

Diabetes care, 2011-12, Vol.34 (12), p.2560-2566

2011

Volltextzugriff (PDF)

A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease

Journal of hepatology, 2023-10, Vol.79 (4), p.888-897

2023

Volltextzugriff (PDF)

Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency

Diabetes care, 2013-05, Vol.36 (5), p.1067-1073

2013

Volltextzugriff (PDF)

Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

Diabetes care, 2017-04, Vol.40 (4), p.494-501

2017

Volltextzugriff (PDF)

Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine

Diabetes care, 2022-01, Vol.45 (1), p.204-212

2022

Volltextzugriff (PDF)

A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT‐R study

Diabetes, obesity & metabolism, 2018-12, Vol.20 (12), p.2876-2884

2018

Volltextzugriff (PDF)

Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial

Diabetes care, 2017-12, Vol.40 (12), p.1763-1770

2017

Volltextzugriff (PDF)

Corifollitropin Alfa Combined With Human Chorionic Gonadotropin in Adolescent Boys With Hypogonadotropic Hypogonadism

The journal of clinical endocrinology and metabolism, 2022-06, Vol.107 (7), p.2036-2046

2022

Volltextzugriff (PDF)

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin

Diabetes, obesity & metabolism, 2021-09, Vol.23 (9), p.2099-2108

2021

Volltextzugriff (PDF)

Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes

Diabetes care, 2015-11, Vol.38 (11), p.2106-2114

2015

Volltextzugriff (PDF)

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial

Diabetes, obesity & metabolism, 2017-01, Vol.19 (1), p.78-86

2017

Volltextzugriff (PDF)

Androgens and alopecia

Molecular and cellular endocrinology, 2002-12, Vol.198 (1), p.89-95

Kaufman, Keith D

2002

Volltextzugriff (PDF)

1119-P: Efficacy and Safety of Sitagliptin (SITA) Compared with Dapagliflozin (DAPA) in People ≥65 Years Old with T2D

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

Current medical research and opinion, 2008-02, Vol.24 (2), p.537-550

2008

Volltextzugriff (PDF)

1 – 25 von 256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(214)
Mit Volltextzugriff
(211)

Publikationsform

Sprache

Englisch
(253)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(180)
Life Sciences & Biomedicine
(169)
Humans
(143)
Female
(95)
Male
(90)
Adult
(71)
Middle Aged
(71)
Biological And Medical Sciences
(65)
Aged
(60)
Medical Sciences
(52)
Endocrinology & Metabolism
(46)
Double-Blind Method
(45)
Diabetes
(38)
Diabetes Mellitus, Type 2 - Drug Therapy
(36)
Treatment Outcome
(32)
Adolescent
(25)
Aged, 80 And Over
(23)
Animals
(23)
Hypoglycemic Agents - Therapeutic Use
(23)
Surgery
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Metabolic syndrome: a clinical and molecular perspective

A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus

Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease

Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial

Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies

Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo

A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin

Randomized clinical trial of the safety and efficacy of sitagliptin and metformin co‐administered to Chinese patients with type 2 diabetes mellitus

Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis

Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes

A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease

Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency

Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine

A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT‐R study

Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial

Corifollitropin Alfa Combined With Human Chorionic Gonadotropin in Adolescent Boys With Hypogonadotropic Hypogonadism

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin

Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial

Androgens and alopecia

1119-P: Efficacy and Safety of Sitagliptin (SITA) Compared with Dapagliflozin (DAPA) in People ≥65 Years Old with T2D

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

Suchergebnisse filtern